149 related articles for article (PubMed ID: 37604872)
1. Deposition of complement components C5b-9 and MASP2 in tissues is not a feature of GVHD and may assist in discriminating GVHD from thrombotic microangiopathy following allogenic transplantation.
Alhomoud M; Magro C; Seshan S; Zhang T; Gomez-Arteaga A; Chokr N; Yamshon S; Phillips A; Mayer S; Shore T; Laurence J
Bone Marrow Transplant; 2023 Nov; 58(11):1270-1274. PubMed ID: 37604872
[No Abstract] [Full Text] [Related]
2. C5b-9 and MASP2 deposition in skin and bone marrow microvasculature characterize hematopoietic stem cell transplant-associated thrombotic microangiopathy.
Elhadad S; Chadburn A; Magro C; Van Besien K; Roberson EDO; Atkinson JP; Terry H; Greenberg J; Reid W; Chapin J; Copertino D; Geramfard S; Rodriguez LB; Orfali N; Gerghis U; Shore T; Mayer S; Ahamed J; Laurence J
Bone Marrow Transplant; 2022 Sep; 57(9):1445-1447. PubMed ID: 35661836
[No Abstract] [Full Text] [Related]
3. [Changes in diagnostic criteria of thrombotic microangiopathy after stem cell transplantation].
Horváth O; Prohászka Z; Kállay K; Kassa C; Stréhn A; Csordás K; Sinkó J; Kriván G
Orv Hetil; 2017 Jul; 158(27):1043-1050. PubMed ID: 28670985
[TBL] [Abstract][Full Text] [Related]
4. Early Increase in Complement Terminal Pathway Activation Marker sC5b-9 Is Predictive for the Development of Thrombotic Microangiopathy after Stem Cell Transplantation.
Horváth O; Kállay K; Csuka D; Mező B; Sinkovits G; Kassa C; Stréhn A; Csordás K; Sinkó J; Prohászka Z; Kriván G
Biol Blood Marrow Transplant; 2018 May; 24(5):989-996. PubMed ID: 29339271
[TBL] [Abstract][Full Text] [Related]
5. Complement-mediated thrombotic microangiopathy as a link between endothelial damage and steroid-refractory GVHD.
Wall SA; Zhao Q; Yearsley M; Blower L; Agyeman A; Ranganathan P; Yang S; Wu H; Bostic M; Jaglowski S; Brammer JE; William B; Choe H; Mims AS; Penza S; Efebera Y; Devine S; Cataland S; Davies SM; Vasu S
Blood Adv; 2018 Oct; 2(20):2619-2628. PubMed ID: 30327370
[TBL] [Abstract][Full Text] [Related]
6. MASP2 levels are elevated in thrombotic microangiopathies: association with microvascular endothelial cell injury and suppression by anti-MASP2 antibody narsoplimab.
Elhadad S; Chapin J; Copertino D; Van Besien K; Ahamed J; Laurence J
Clin Exp Immunol; 2021 Jan; 203(1):96-104. PubMed ID: 32681658
[TBL] [Abstract][Full Text] [Related]
7. Diagnosis of intestinal graft-versus-host disease and thrombotic microangiopathy after allogeneic stem cell transplantation.
Yamada-Fujiwara M; Miyamura K; Fujiwara T; Tohmiya Y; Endo K; Onishi Y; Ishizawa K; Kameoka J; Ito M; Harigae H
Tohoku J Exp Med; 2012 May; 227(1):31-7. PubMed ID: 22531159
[TBL] [Abstract][Full Text] [Related]
8. Linking Complement Activation, Coagulation, and Neutrophils in Transplant-Associated Thrombotic Microangiopathy.
Gavriilaki E; Chrysanthopoulou A; Sakellari I; Batsis I; Mallouri D; Touloumenidou T; Papalexandri A; Mitsios A; Arampatzioglou A; Ritis K; Brodsky RA; Mitroulis I; Anagnostopoulos A
Thromb Haemost; 2019 Sep; 119(9):1433-1440. PubMed ID: 31266080
[TBL] [Abstract][Full Text] [Related]
9. Severe diarrhea following bone marrow transplantation is not always caused by GVHD.
De Petris G; Corominas Cishek A; Dzeletovic I
Gastroenterology; 2014 Jun; 146(7):e5-6. PubMed ID: 24786559
[No Abstract] [Full Text] [Related]
10. Intestinal thrombotic microangiopathy: a distinct entity in the spectrum of graft-versus-host disease.
Gavriilaki E; Sakellari I; Karafoulidou I; Pasteli N; Batsis I; Mallouri D; Lazaridou A; Iskas M; Vardi A; Papalexandri A; Tsompanakou A; Papaemmanouil S; Ilias A; Anagnostopoulos A
Int J Hematol; 2019 Nov; 110(5):529-532. PubMed ID: 31586304
[TBL] [Abstract][Full Text] [Related]
11. Predictors of Transplant-Associated Thrombotic Microangiopathy in Patients With Overlap or Chronic Graft-vs-Host-Disease.
Gavriilaki E; Sakellari I; Chatzikonstantinou T; Bousiou Z; Mallouri D; Masmanidou M; Vardi A; Koravou EE; Kika F; Touloumenidou T; Papalexandri A; Yannaki E; Batsis I; Anagnostopoulos A
Transplant Proc; 2021 Sep; 53(7):2261-2266. PubMed ID: 34417030
[TBL] [Abstract][Full Text] [Related]
12. Hematopoietic Stem Cell Transplant-Associated Thrombotic Microangiopathy.
Elsallabi O; Bhatt VR; Dhakal P; Foster KW; Tendulkar KK
Clin Appl Thromb Hemost; 2016 Jan; 22(1):12-20. PubMed ID: 26239316
[TBL] [Abstract][Full Text] [Related]
13. A critical role of the Gas6-Mer axis in endothelial dysfunction contributing to TA-TMA associated with GVHD.
Furukawa M; Wang X; Ohkawara H; Fukatsu M; Alkebsi L; Takahashi H; Harada-Shirado K; Shichishima-Nakamura A; Kimura S; Ogawa K; Ikezoe T
Blood Adv; 2019 Jul; 3(14):2128-2143. PubMed ID: 31300420
[TBL] [Abstract][Full Text] [Related]
14. Thrombotic microangiopathy with concomitant GI aGVHD after allogeneic hematopoietic stem cell transplantation: Risk factors and outcome.
Zhang XH; Liu X; Wang QM; He Y; Zhu XL; Zhang JM; Han W; Chen H; Chen YH; Wang FR; Wang JZ; Zhang YY; Mo XD; Chen Y; Wang Y; Fu HX; Chang YJ; Xu LP; Liu KY; Huang XJ
Eur J Haematol; 2018 Feb; 100(2):171-181. PubMed ID: 29114931
[TBL] [Abstract][Full Text] [Related]
15. Renal dysfunction following bone marrow transplantation.
Kemmner S; Verbeek M; Heemann U
J Nephrol; 2017 Apr; 30(2):201-209. PubMed ID: 27589851
[TBL] [Abstract][Full Text] [Related]
16. Thrombotic microangiopathy mediates poor prognosis among lupus nephritis
Zhang B; Xing G
Front Immunol; 2022; 13():1081942. PubMed ID: 36582241
[TBL] [Abstract][Full Text] [Related]
17. Complement Activation and Thrombotic Microangiopathies.
Palomo M; Blasco M; Molina P; Lozano M; Praga M; Torramade-Moix S; Martinez-Sanchez J; Cid J; Escolar G; Carreras E; Paules C; Crispi F; Quintana LF; Poch E; Rodas L; Goma E; Morelle J; Espinosa M; Morales E; Avila A; Cabello V; Ariceta G; Chocron S; Manrique J; Barros X; Martin N; Huerta A; Fraga-Rodriguez GM; Cao M; Martin M; Romera AM; Moreso F; Manonelles A; Gratacos E; Pereira A; Campistol JM; Diaz-Ricart M
Clin J Am Soc Nephrol; 2019 Dec; 14(12):1719-1732. PubMed ID: 31694864
[TBL] [Abstract][Full Text] [Related]
18. Successful Treatment of Veno-occlusive Disease, Transplantation-Associated Thrombotic Microangiopathy, and Acute Graft-vs-Host Disease in a Patient with Relapsed Epstein-Barr Hemophagocytic Lymphohistiocytosis After Haploidentical Hematopoietic Stem Cell Transplantation: A Case Report.
Zhang C; Tan X; Yao H; Liu Y; Gao L; Gao L; Kong PY; Zhang X
Transplant Proc; 2019 Nov; 51(9):3159-3162. PubMed ID: 31711585
[TBL] [Abstract][Full Text] [Related]
19. Complement as the enabler of carfilzomib-induced thrombotic microangiopathy.
Blasco M; Martínez-Roca A; Rodríguez-Lobato LG; Garcia-Herrera A; Rosiñol L; Castro P; Fernández S; Quintana LF; Cibeira MT; Bladé J; Fernández de Larrea C; Tovar N; Jimenez R; Poch E; Guillen E; Campistol JM; Carreras E; Diaz-Ricart M; Palomo M
Br J Haematol; 2021 Apr; 193(1):181-187. PubMed ID: 32469083
[TBL] [Abstract][Full Text] [Related]
20. Renal Complications after Hematopoietic Stem Cell Transplantation: Role of Graft-Versus-Host Disease in Renal Thrombotic Microangiopathy.
Mii A; Shimizu A; Yamaguchi H; Tsuruoka S
J Nippon Med Sch; 2020 Mar; 87(1):7-12. PubMed ID: 31776318
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
